Brands Headquartered in Tokyo

Prescription stem cell therapy originally approved in Europe for treating complex perianal fistulas in adult Crohn's disease patients, developed by TiGenix and acquired by Takeda.

Sony's interchangeable-lens camera brand, spanning full-frame and APS-C mirrorless systems, for professional photographers and serious enthusiasts.

Premium Japanese streetwear and sneaker boutique founded in Tokyo in 2000, now owned by Dick's Sporting Goods, focused on Japan and Asia-Pacific markets with exclusive brand collaborations.

Sony's premium television brand offering RGB mini-LED, OLED, and QD-OLED displays. In March 2026, Sony and TCL signed definitive agreements to transfer Bravia operations to a joint venture called BRAVIA Inc. (TCL 51%, Sony 49%), expected to begin operations in April 2027.

Prescription proton pump inhibitor (dexlansoprazole) for treating GERD and erosive esophagitis, manufactured by Takeda Pharmaceutical Company.

Japanese casual fashion brand offering trendy, affordable clothing for young consumers, owned by Fast Retailing Co., Ltd.

Japanese automobile manufacturer and member of the Renault-Nissan-Mitsubishi Alliance, known for SUVs and reliable vehicles.

Takeda's oral proteasome inhibitor (ixazomib citrate), FDA approved November 20, 2015, as the first and only oral proteasome inhibitor approved for multiple myeloma, used in combination with lenalidomide and dexamethasone for adult patients with relapsed or refractory multiple myeloma who have received at least one prior therapy, based on the TOURMALINE-MM1 Phase 3 trial.

Sony's video gaming brand encompassing consoles, games, and online gaming services.

Fifth generation home video game console developed by Sony Interactive Entertainment, featuring advanced graphics and SSD technology.

Japanese casual fashion brand owned by Fast Retailing, offering comfortable, versatile clothing for working adults who want quality everyday wear at accessible prices.

Japanese media franchise managed by The Pokémon Company, encompassing video games, trading cards, anime series, films, and merchandise.

Takeda's selective melatonin MT1 and MT2 receptor agonist (ramelteon) for insomnia, FDA approved July 22, 2005, as the first prescription sleep aid with no abuse potential and no DEA scheduling, indicated for sleep-onset insomnia in adults, available as an 8 mg film-coated tablet taken 30 minutes before bedtime.

Japanese multinational conglomerate brand specializing in electronics, entertainment, gaming, and financial services, flagship brand of Sony Group Corporation.

Japanese automobile manufacturer known for its standard symmetrical all-wheel drive system, boxer engines, and strong safety reputation.

Takeda's non-purine selective xanthine oxidase inhibitor (febuxostat) for chronic gout, originally discovered by Teijin Pharma in Japan, FDA approved in February 2009, subject to a black box warning added in February 2019 for increased risk of cardiovascular death and all-cause mortality compared to allopurinol based on the CARES trial, with use now restricted to patients who have failed or cannot tolerate allopurinol.

Japanese casual wear brand known for its LifeWear philosophy of high-quality, affordable everyday clothing with innovative fabric technology, owned by Fast Retailing Co., Ltd.

Takeda's once-daily amphetamine prodrug (lisdexamfetamine dimesylate) for ADHD and binge eating disorder, originally developed by New River Pharmaceuticals and acquired by Shire in 2007 (the year of FDA approval), with Takeda inheriting the brand through its $62 billion acquisition of Shire in 2019, before generic lisdexamfetamine was approved in 2023.

Sony's iconic portable audio brand offering music players, headphones, and audio devices for music enthusiasts and consumers.

Sony's smartphone and mobile device brand offering Android-based smartphones with advanced camera and display technology.